FDA Adverse Event Malfunction Summary report: N

REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

MDR report key: 24916773 · Received April 17, 2026

Report

Report Number
3016798778-2026-00098
Event Type
Malfunction
Date Received
April 17, 2026
Date of Event
March 17, 2026
Report Date
April 17, 2026
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QJY
UDI-DI
00850017421035
PMA / PMN Number
K202690
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

EFFORTS TO OBTAIN ADDITIONAL INFORMATION FROM ACCREDO SPECIALTY PHARMACY WERE UNSUCCESSFUL. PATIENTS ARE FURNISHED WITH A BACKUP REMUNITY SYSTEM TO ENSURE UNINTERRUPTED DRUG DELIVERY; HOWEVER, BASED ON THE INFORMATION AVAILABLE, IT IS UNKNOWN IF THE PATIENT WAS ABLE TO SWITCH TO THEIR BACKUP SYSTEM AT THE TIME OF THE EVENT. AT THIS TIME, NO COMPONENTS OR ADDITIONAL INFORMATION HAVE BEEN MADE AVAILABLE TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY UNITED THERAPEUTICS DRUG SAFETY ON 20-MAR-2026 FROM ACCREDO SPECIALTY PHARMACY, AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC ON 21-MAR-2026. IT WAS REPORTED THAT THE PATIENT WAS HOSPITALIZED FROM ON (B)(6) 2026 DUE TO AN ISSUE WITH THEIR REMUNITY PUMP. NO FURTHER INFORMATION REGARDING THE SPECIFIC TYPE OF DEVICE ISSUE WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
970526 REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION INFUSION PUMP QJY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-11042-001 00850017421035

Patients

Seq Age Sex Outcome Treatment
1 57 YR Female Hospitalization B COMPLEX TABLET.| BIOTIN.| CLARITIN.| JARDIANCE.| LIDOCAINE.| METHIMAZOLE.| METOPROLOL SUCCINATE.| OMEPRAZOLE.| OXYGEN.| POTASSIUM CHLORIDE.| SPIRONOLACTONE.| TORSEMIDE.| VITAMIN C.| VITAMIN D3.| XARELTO.